7 February 2018 - - Bridgewater, New Jersey-based generic pharmaceutical manufacturer Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP in 18, 27, 36, and 54 mg strengths, the company said.
Amneal's methylphenidate is an AB-rated equivalent to the brand Concerta. The Amneal ANDA included all bioequivalence metrics recommended by FDA.
Methylphenidate hydrochloride ER tablets are now shipping to wholesalers, distributors and direct to the trade. All strengths are available in 90-ct bottles with a 30-ct size available upon request. The product is manufactured in the USA. at the Amneal plant in Brookhaven, New York.
Privately-held Amneal Pharmaceuticals is a US generics pharmaceutical manufacturer with more than 5,000 employees in North America, Asia and Europe, working together to bring high-quality affordable medicines to patients worldwide.
The company has significantly expanded its portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas.